Strategic Plan for Addressing the Recommendations of the Pancreatic Cancer Progress Review Group

摘要

Pancreatic Cancer, diagnosed in more than 29,000 people every year, is the fifth leading cause of cancer death in the U.S.. Most people with pancreatic cancer die within six months. Despite these tragic statistics, pancreatic cancer remains underrepresented in both clinical and basic research compared with other cancer sites. Future success will require a renewed commitment to focused scientific research, a robust infrastructure of supporting resources, and active coordination within the scientific and medical community. In an effort to help identify challenges ahead, the Pancreatic Cancer Progress Review Group (PanC PRG) has produced the first report of recommendations for progress and priorities in the area of pancreatic cancer research.